The CancerenD24: A Novel Blood Test That Can Prevent Colorectal Cancer
CD24 levels increase early in CRC carcinogenesis, detectable already at the level of adenomas >5 mm. CancerenD24, as a noninvasive screening tool, shows promise as an aid to clinicians in identifying at-risk individuals and may reduce reliance on colonoscopy. Further validation is ongoing.
Authors
- Lior Galazan
- Nadir Arber (ORCID: https://orcid.org/0000-0001-5283-6991)
- H Bruck
- Shiran Shapira (ORCID: https://orcid.org/0000-0002-3974-5910)
- Netanel Deutsch
- Lisa Deutsch (ORCID: https://orcid.org/0000-0002-1950-5522)
- Hadas Yaakobi
- Dina Kazanov
- Mays Motlaq
- Roman Greenshpon
Institutions
- Tel Aviv University (IL)
Publication Details
- Journal
- Gastro Hep Advances
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.gastha.2025.100757
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00